Plain-English translation of NCT05081024 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a blood test that detects cancer DNA to help doctors make better treatment decisions for rectal cancer patients. Right now, most people with rectal cancer have surgery after chemotherapy and radiation, even if the cancer has completely disappeared. This study wants to see if a blood test can identify which patients have truly cleared their cancer, so they might avoid surgery and its side effects.
Surgery to remove the rectum can affect quality of life for many patients. If doctors could reliably predict which patients no longer have cancer using a simple blood test, some people might be able to skip surgery altogether and still be cured.
You likely qualify if…
You likely don't qualify if…
You will give blood samples several times over about 3 years: once before treatment starts, every 2 months while you're receiving chemotherapy and radiation, and then every 3 months after treatment ends. The study team will also review your medical records and may collect a small tissue sample if one isn't already available from your diagnosis. All of this helps researchers understand how the blood test performs and whether it can guide future treatment decisions.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States